Skip to content

Supplier News

Lannett to ship Loxitane generic

Lannett Co. has received approval from the Food and Drug Administration for loxapine capsules, an anti-psychotic medication. The generic pharmaceutical company said Tuesday that the loxapine capsules will be available in strengths of 5 mg, 10 mg, 25 mg and 50 mg.

Vicks kicks off NFL fan contest

With the National Football League season now under way, Procter & Gamble’s Vicks NyQuil and DayQuil cold/cough/flu medicine brands have launched their "Most Dedicated Fan" contest on Facebook.

Dr. Reddy’s ships generic version of Exelon

Dr. Reddy’s Laboratories has launched rivastigmine tartrate capsules, a treatment for dementia caused by Alzheimer’s or Parkinson’s disease, in the U.S. market. The pharmaceutical company said Thursday that its rivastigmine tartrate capsules are available in strengths of 1.5 mg, 3 mg, 4.

Advil to air TV spots featuring Regis Philbin

Next month, Advil plans to launch a television advertisements featuring TV personality Regis Philbin and his wife Joy as part of the pain reliever’s "True Advil Stories" campaign. The Pfizer pain relief brand said Thursday that the TV commericals are available now on the TakeAdvil.

PhRMA names new board members

The Pharmaceutical Research and Manufacturers of America (PhRMA) has elected EMD Serono Inc. president James Hoyes and Ikaria Inc. chairman and chief executive officer Daniel Tassé to its board of directors. "We are pleased to welcome two outstanding industry leaders, Mr. Hoyes and Mr.

Watson, Amphastar to launch Lovenox generic

Watson Pharmaceuticals Inc. announced that Amphastar Pharmaceuticals Inc. has received Food and Drug Administration approval for enoxaparin sodium injection, a blood thinner, in strengths of 100mg/ml and 150mg/ml.

La Roche-Posay marks successful sun protection campaign

La Roche-Posay said it had a "successful summer" with its "SOS – Save Our Skin" sun protection campaign The UV protection skin care company said Wednesday that in this campaign, now in its second year, over 40 volunteer dermatologists were stationed at nearly 30 events nationwide, performing more th

Insight Pharmaceuticals acquires Monistat

Insight Pharmaceuticals has acquired the Monistat feminine care North American brand portfolio from McNeil-PPC Inc. Insight said Tuesday that vaginal antifungal brand joins its roster of over-the-counter women’s health and personal care products, which include leading brands such as e.p.